Literatur
-
1
Barth P M, Lindenstrom E, Boysen G. et al .
Tinzaparin in acute ischemic stroke (TAIST).
Lancet.
2001;
358
702-710
-
2
EAFT Study group .
Secondary Prevention in non rheumatic Atrial Fibrillation after transient ischemic attack or minor stroke.
Lancet.
1993;
342
1255-1262
-
3
EAFT Study group .
Optimal Anticoagulant Therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia.
N Engl J Med.
1995;
333
5-10
-
4
Hart R G, Pearce L A, Rothbarth R M. et al. For the stroke prevention in Atrial Fibrilation investigators .
Stroke with intermittent atrial fibrillation: Incidence and predictors during aspirin therapy.
J Am Cardiol.
2000;
36
324
-
5
Laupacis A, Albers G, Dalen J. et al .
Antithrombotic therapy in Atrial Fibrillation (5.ACCP-Konsensus Konferenz).
CHEST.
1998;
114
579S-589S
-
6
Von Knorre G H.
Antikoagulation bei supraventrikulären Tachyarrhythmien.
Internist.
1998;
39
38-45
Prof. Dr. med. M. Leschke
Dr. med. W. Klimek
Städtische Kliniken Esslingen, Fachbereich Kardiologie
Hirschlandstraße 97
73730 Esslingen
Email: m.leschke@kliniken-es.de
Email: waldemar@klimek.com
